The Chinese Laboratory Sinopharm CNBG He maintained that the journalistic report that questions the efficacy of the COVID-19 vaccine “is severely lacking in veracity and is extremely irresponsible.”
–
In a statement, he warned that the report revealed “unverified, unscientific, imprecise and incomplete data”, which can confuse public opinion.
–
“The parameters and methodologies taken for the data in the report do not comply with the requirements of the approved protocol or international standards. The inactivated vaccine against COVID-19 adopts an international multicenter, double-blind and placebo-controlled method to evaluate its safety and protective efficacy, ”says the document released by the Chinese Embassy in Peru.
–
He added that currently the adjudications of COVID-19 cases are made in accordance with the requirements of the protocol and “the definitive data of the clinical trial in Peru have not been generated.”
–
“The data in the report are incomplete, unscientific, and do not fully or authentically reflect the protective effect of the vaccine. They have no reference value,” Sinopharm stressed.
–
Finally, it indicates that with respect to “said false reports”, the laboratory “reserves the right to demand responsibilities”.
–
